Hemorragia por várices esofágicas. Alternativas actuales de tratamiento
Contenido principal del artículo
Resumen
El manejo de la hemorragia secundaria a várices esofágicas continúa evolucionando. Contando con un mayor número de opciones de tratamiento, el reto es proporcionar las más óptimas. El único tratamiento profiláctico aceptado hasta la fecha es el farmacológico.
El manejo del episodio agudo requiere instalar de inmediato adecuadas medidas de reanimación y manejo específico que incluye tratamiento farmacológico y endoscópico. Hay un papel muy limitado para procedimientos de descompresión en el episodio agudo de hemorragia.
La prevención de hemorragia recurrente incluye varias fases de tratamiento: tratamiento farmacológico, endoscópico o ambos, procedimientos de descompresión y trasplante hepático.
El manejo de la hemorragia secundaria a várices esofágicas requiere una estrecha colaboración y coordinación de un equipo multidisciplinario.
Detalles del artículo
Cómo citar
Referencias
Navarro VJ, Garcia-Tsao G. Variceal hemorrhage. Crit Care Clin 1995; 11(2): 391-414.
Roberts LR, Kamath PS. Pathophysiology and treatment of variceal hemorrhage. Mayo Clin Proc 1996; 71: 973-83.
D’amico G, Pagliaro L, Bosch J. The treatment of hypertension portal: A meta-analytic review. Hepatology 1995; 22(1); 332-54.
Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Hepatology 1995; 22(6): 1754-62.
Burroughs AK, Panagou E. Pharmacological therapy for portal hypertension: Rationale and results. Semin Gastrointest Dis 1995; 6(3): 148-64.
Villanueva C, Balanzo J, Novella MT. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleedding. N Engl J Med 1996; 334: 1624-29.
Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron JP, Poupon R et al. A randomized controlled study of propanolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report. Hepatology 1984; 4: 355-58.
Orozco H, Mercado MA, González HQ, Plata JJ, Flores Alejandro. Surgical treatment of portal hypertension: Portosystemic shunting procedures and devascularizations. Cir Gen 1998; 20(3): 179-87.
Zimmon DS. Endoscopic esophagogastric balloon tamponade. Gastrointest Endosc 1994; 40(6): 734-40.
Silvain C, Carpentier S, Sautereaud D, Czemichow B, Metreau JM, Fort E et al. Terlipressin plus transdermal nitroglycerin vs. octeotrido in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 1993; 18(1): 61-5.
Sung JJ, Chung SC, Lai CW, Chang FK, Leung JW, Young MI et al. Octeotride infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993; 342: 637-41.
Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Betaadrenergic antagonist in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. Hepatology 1997; 25(1): 63-70.
Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analysis. Ann Intern Med 1995; 123(4): 280-7.
Hashizume M, Ohta M, Leno K, Tanoue K, Kitano S, Sugimachi K. Endoscopic ligation of esophageal varices compared with injection sclerotherapy: A prospective randomized trial. Gastrointes Endosc 1993; 39(2): 123-6.
Heaton ND, Howard ER. Complications and limitations of injection sclerotherapy in portal hypertension. Gut 1993; 34(1): 7-10.
Ferral H, Alcántara PA, Kimura FI, Castañeda WZ. Transjugular portosystemic shunt. Current concepts. Rev Gastroenterol Mex 1994; 59(4): 317-23.
Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic shunt versus small-diameter prosthetic H-graft portocaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224(3): 378-86.
McCormick PA, Dick R, Panagou EB, Chin JK, Greenslade L, McIntyre N, Burroughs AK. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81(9): 1324-7.
Catchpile RM. Transjugular intrahepatic portosystemic shunt (TIPS): Diagnostic and therapeutic technology assessment (DATTA). JAMA 1995; 273(23): 1824-30.
Rikkers LF, Jin G. Surgical management of acute variceal hemorrhage. World J Surg 1994; 18: 193-9.
Stipa S, Balducci G, Ziparo V, Stipa F, Lucandri G. Total shunting and elective management of variceal bleeding. World J Surg 1994; 18: 200-04.
Johansen K. Prospective comparison of partial versus total portal decompression for bleeding esophageal varices. Surg 1992; 175: 528-34.
Anderson JM. Rote of distal splenorenal shunt for long-term management of variceal bleeding. World J Surg 1994; 18: 205-10.
Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thoracic Cardiovasc Surg 1973; 66: 677-81.
Orozco H, Mercado MA, Takahashi T, Rohas G, Hernández J, Tielve M. Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg 1994; 168: 10-14.
Idezuky Y, Kokuda N, Sanjo K, Bandai I. Sugiura procedure for management of variceal bleeding in Japan.
Dagenais M, Langer B, Taylor BR, Greig PD. Experience with radical esophagogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan. World J Surg 1994; 18: 222-8.
Jin G, Rikkers LF. Transabdominal esophagogastric devascularization as treatment for variceal hemorrhage.
Ringe B, Lang H, Tusch G, Pichlmayr R. Role of liver transplantation in management of esophageal variceal hemorrhage. World J Surg 1994; 18: 233-9.
Anderson JM, Gilmore GT, Hooks MA. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992; 216(1): 248-55.
Menegaux F, Keeffe EB, Baker E. Comparison of transjugular and surgical portosystemic shunt on the outcome of liver transplantation. Arch Surg 1994; 129: 1018-24.